InvestorsHub Logo
Followers 300
Posts 12061
Boards Moderated 6
Alias Born 02/02/2014

Re: None

Friday, 09/18/2020 8:55:25 AM

Friday, September 18, 2020 8:55:25 AM

Post# of 58510
Key Points from PR dated September 17, 2020:

Highlights Include:

- $300K+ in Purchase Orders for 3 months ended July 31, 2020.

- $151,630 booked as Gross Sales.

- $446,959 Total Assets as of July 31, 2020 vs $48,351 as of April 30, 2020.

- Total Assets up 824% increase on a sequential quarterly basis & up 2,200% annually.

- Cash up 2,580% on a sequential quarterly basis & up over 6,700% annually.

- Inventory valued at $62,500 of July 31,2020.

- Accounts receivable valued at $86,293 of July 31, 2020.

-Turning point for GenTech - in terms of the establishment of robust and accelerating growth - came with acquisition of Sinister Labs, LLC, and the Sinfit Nutrition brand in June.

- "This is a strong and growing brand with a massive domestic and international distribution footprint in the booming functional foods market space."

- "Our July quarter set multiple Company records."

- "Our October quarter is on pace to handily set new ones."

- 43% increase in total outstanding GenTech common shares during the three months ended July 31, 2020 represents the overall equity cost of the Sinfit acquisition.

- This increase in total outstanding shares is already being balanced by sharp growth in cash, assets, sales, and the overall business backed by that equity.

- Total liabilities held steady from April to July while total assets grew by over 800%.

- The company anticipates this growth to continue and likely accelerate over the coming 12 months.

- The company continues to project a potential for over $3 million in sales in 2021 - an extrapolation from the current performance and recent growth trend.



Full-career military veteran now trading OTC stocks for multiple $6-figure profits annually.

All posts are my opinion - trade at your own risk.